BioPlex 2200 anti-CCP assay test

Tuesday, 30 March, 2010 | Supplied by: Bio-Rad Laboratories


The BioPlex 2200 anti-CCP test, based on Axis-Shield’s anti-CCP technology, can be used for the early detection of rheumatoid arthritis. The assay measures anti-CCP (anti-cyclic citrullinated peptide antibodies), a novel marker that has been shown to have good specificity in the diagnosis of rheumatoid arthritis.

The measurement of these antibodies is claimed to have recently been cited as a key parameter in the definitive diagnosis of rheumatoid arthritis by the American College of Rheumatology.

The BioPlex 2200 system is an automated, random-access multiplex testing platform with an assay menu targeting autoimmune diagnostics and infectious diseases. The anti-CCP kit is pending clearance by the US FDA.

Online: www.bio-rad.com
Phone: 0011 1 510 724 7000
Related Products

ALA Scientific Instruments RuFus cell unroofing system for plasma membrane isolation

ALA Scientific Instruments offers RuFus, a complete and user-friendly system for performing cell...

Lonza plateable mouse hepatocytes

Lonza provides plateable mouse hepatocytes from the four most common research mouse strains,...

PEPperPRINT cLIFT peptide microarray platform

At the core of the technology is a laser-based transfer process that is designed to deposit amino...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd